Telephone: 858.812.7700
Investor Relations
Jim Schoeneck, CEO
jschoeneck@braincellsinc.com
Business Development
Jason Levin, Chief Business Officer
jlevin@braincellsinc.com
Human Resources
Human Resources Director
hrdirector@braincellsinc.com
Public Relations
Kim Richards
Canale Communications, Inc.
kim@canalecomm.com
News
News Archives: 2010 | 2009 | 2008 | 2007 | 2006 | 2005
Press Releases
August 4, 2010
BrainCells Inc. Acquires Clinical -Stage Compound Sabcomeline From Proximagen Group
June 14, 2010
BrainCells Inc. Announces Results From Exploratory Phase 2a Trial of BCI-540 in Depression With Anxiety
April 29, 2010
BrainCells Issued First U.S. Patent For Drug Combinations That Modulate Neurogenesis
More Press Releases »BrainCells in the News
June 1, 2010
BrainCells Reveals New BCI-540 Phase II Data
Neurotech Insights. 2010 June 1.
September 3, 2009
BrainCells Inc., Defying Convention, Suggests Novel Drug Combination Can Treat Depression
Xconomy. 2009 September 3.
June 1, 2009
Emerging Leaders: Carrolee Barlow, MD, PhD
Pharmaceutical Executive. 2009 June.
More News Items »